Catalys Pacific, LLC — Q4 2023 13F-HR

← Catalys Pacific, LLC

Q4 2023 · 13F-HR

Catalys Pacific, LLCholdings as filed

Filed 2024-02-14 · accession 0001104659-24-022986

$106.7M

Reported value

Positions

2023-12-31

Period end

View analyzed profile →PRO

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
603170101	MLYS	Mineralys Therapeutics, Inc.	$79.1M	74.1%	9,194,579	Common	SOLE
43157M102	—	HilleVax, Inc.	$21.0M	19.7%	1,308,974	Common	SOLE
71722W107	PHAT	Phathom Pharmaceuticals, Inc.	$6.6M	6.18%	721,962	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.